A remedy and/or a preventive for a chronic disease which contains an EDG-2 antagonist. Because of binding to a subtype EDG-2 of LPA receptor, an EDG-2 antagonist is useful in treating and/or preventing chronic diseases (for example, diseases caused by the progress of chronic asthma, glomerular nephritis, obesity, arteriosclerosis, rheumatoid and atopic diseases) induced and made chronic by tissue cells whose proliferation is accelerated by LPA mediated by EDG-2.
[Fe(F20TPP)Cl] catalyzed intramolecular C–N bond formation for alkaloid synthesis using aryl azides as nitrogen source
作者:Yungen Liu、Jinhu Wei、Chi-Ming Che
DOI:10.1039/c0cc01825b
日期:——
tetrahydroquinolines, dihydroquinazolinones and quinazolinones have been accomplished in moderate to excellent yields via [Fe(F(20)TPP)Cl] catalyzed intramolecular C-N bond formation usingarylazides as nitrogensource.